The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
Rajah
A
A
Department of Anaesthetics, Hammersmith Hospital, London.
D002648:Child; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage; D007262:Infusions, Intravenous; D008297:Male; D011129:Polyradiculoneuropathy / Q000503:physiopathology / Q000628:therapy*; D014797:Vital Capacity / Q000502:physiology
D007136:Immunoglobulins